Advertisement
Next frontier of bone regeneration
In July 2012 IBI introduced SmartBone® on the EU and international market: an innovative bone substitute produced by combining a bovine mineral bone matrix with bioresorbable polymers and collagen fragments.
SmartBone® is CE marked according to 93/42/EEC Medical Device Directive classified as a class III Medical Device.
In July 2012 IBI introduced SmartBone® on the EU and international market: an innovative bone substitute produced by combining a bovine mineral bone matrix with bioresorbable polymers and collagen fragments.
SmartBone® is CE marked according to 93/42/EEC Medical Device Directive classified as a class III Medical Device.
Hall 3.2 | E020 F021